Recruit Top Talent at the 2008 ISCT Annual Meeting
The inaugural Cell Therapy News and ISCT Joint Job Posting program is the perfect opportunity to highlight your organization, profile open positions, and recruit highly qualified cell therapy professionals from a captive audience of cell therapy experts, including scientists, technologists, and business professionals.
Click here to particpate in this program.
UConn Researchers Take First Step Toward Arthritis Treatment
The research team has been able to turn embryonic stem cells into the cells that make up cartilage, which is the tissue at the surface of joints that allows movement.
Scientists Successfully Awaken Sleeping Stem Cells
Scientists at Schepens Eye Research Institute have discovered what chemical in the eye triggers the dormant capacity of certain non-neuronal cells to transform into progenitor cells, a stem-like cell that can generate new retinal cells.
Texas Tech Researchers Discover Two Proteins that Regulate Potassium in Stem Cells
Researchers at Texas Tech University and the University of Wisconsin have discovered two proteins that control potassium regulation in stem cells found in the embryonic brain of rats.
Way to Target Genes Devised for Gene Therapy
Sir Aaron Klug, a Nobel laureate working at the Medical Research Council’s Laboratory of Molecular Biology in Cambridge, has developed a more efficient way to target genes, so gene therapy can be done with surgical precision.
Novel Approach May Spell Safer Gene Therapy
A novel strategy for circumventing safety problems that have plagued gene therapy has been offered by a complex multicenter group of researchers.
Tobacco Plants Get Gene Therapy
Knocking out a specific gene in burley tobacco plants significantly reduces harmful carcinogens in cured tobacco leaves, scientists at N.C. State University have shown.
Stem Cell Firm in Limbo as Tests Delayed
British stem cell pioneer ReNeuron Group Plc is looking elsewhere to test its experimental stroke treatment ReN001, following a series of delays in the United States.
Targeted Genetics Announces Completion of Dosing for the Phase 1/2 Clinical Trial of tgAAC94 for Inflammatory Arthritis
Targeted Genetics Corporation has announced that dosing has been completed for the Phase 1/2 clinical trial of tgAAC94 for the treatment of inflammatory arthritis.
ProNAi Therapeutics, Inc. Cleared to Begin Phase I Clinical Trials for the First DNA Interference (DNAi(R)) Therapeutic
ProNAi Therapeutics, Inc. has announced that it has received clearance from the U.S. Food and Drug Administration to proceed into Phase I clinical trials with its first drug candidate, PNT2258.
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Isolagen(TM), Inc. has announced the completion of enrollment of approximately 120 patients in its Phase II/III Study IT-A-008 investigating the Isolagen Therapy(TM) for the treatment of moderate to severe acne scars.
Body Snatching Ring Boss ‘Guilty’
The head of a US body-snatching ring accused of stealing the parts of around 1,000 people has pleaded guilty, after striking a deal with prosecutors.
Are Dual Cord Blood Banks the Answer to Increasing Stem Cell Demand?
Virgin recently introduced the concept of dual public-private banking. Virgin Health Bank stores 20% of the sample for private use and 80% for public use and uses some of the proceeds to support stem cell research.
‘A Race to the Starting Line’: Diagnosing What’s Holding Biotechnology Back
New strategies will be necessary for biotechnology companies to thrive in the new era of personalized medicine, but the healthcare system itself will also have to change, according a panel of six biotechnology company representatives who participated in a discussion titled, "Emerging Technologies and the Innovation of Competitive Advantage," at the 2008 Wharton Health Care Business Conference.
Post-ISCF Clinical Grade Stem Cell Banking Meeting
April 19-23, 2008 | Institute of Zoology, Chinese Academy of Sciences, Beijing
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Market for Adult Stem Cells Multiplies
While the research community remains interested in embryonic stem cells, these days the focus is on the potential uses of adult stem cells, where it turns out that significant progress is being made away from the political spotlight.
Regrowing Limbs: Can People Regenerate Body Parts?
Progress on the road to regenerating major body parts, salamander-style, could transform the treatment of amputations and major wounds.
Cardiac Stem Cells in the Real World
These data raise a cautionary note on the therapeutic exploitation of cardiac stem cells in patients with ischemic cardiomyopathy, who may be the elective candidates for regenerative therapy.